The #2 most cited open-access journal in Pharmacology and Pharmacy
Frontiers in Pharmacology publishes tier 1 and tier 2 article types on the most outstanding discoveries across the entire research spectrum of pharmacology including basic pharmacology, clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Pharmacology is a medical science, as was recalled in the anniversary address for the 50th Spring Meeting in Mainz of the German Pharmacological Society in March 2009. This science of the effect of medicinal bodies gives us the handle to clarify the fundamental processes of life. It is also the science studying the interactions between chemicals and living beings directed to prevent, ameliorate or cure the deleterious consequences of their diseases, thereby it provides medicine with weapons against diseases. Those major targets offer the opportunity to segment the field not only in a way considering pure basic topics but also by combining and integrating basic and clinical science. The editorial policy aims at identifying the most productive research projects through an evaluation by the scientific community. Thereby Frontiers editors hope to further pharmacological research. They intend to emphasize a proper use of translational science at both preclinical and clinical levels in order to encourage collaboration between clinicians and basic scientists. Editors welcome papers issued from a collaborative strategy between the academic and the private industrial sectors that could benefit to the reversal of the current decline in the production of original medicines.
Frontiers in Pharmacology is a member of the Committee on Publication Ethics.
Short Name: Front. Pharmacol.
Electronic ISSN: 1663-9812
Indexed in: PubMed, PubMed Central, Scopus, Web of Science, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), Index Copernicus
PMCID: all published articles receive a PMCID
Frontiers in Pharmacology is composed of the following Specialty Sections:
The specialty sections of Frontiers in Pharmacology welcome submission of the following article types: Book Review, Case Report, Clinical Trial, Correction, Data Report, Editorial, General Commentary, Hypothesis & Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Protocols, Review, Specialty Grand Challenge, Technology Report, Research Snapshot, Clinical Study Protocol and Systematic Review.
When submitting a manuscript to Frontiers in Pharmacology, authors must submit the material directly to one of the specialty sections. Manuscripts are peer-reviewed by the Associate and Review Editors of the respective specialty section.
Articles published in the specialty sections above will benefit from the Frontiers impact and tiering system after online publication. Authors of published original research with the highest impact, as judged democratically by the readers, will be invited by the Chief Editor to write a Frontiers Focused Review - a tier-climbing article. This is referred to as "democratic tiering". The author selection is based on article impact analytics of original research published in the Frontiers specialty journals and sections. Focused Reviews are centered on the original discovery, place it into a broader context, and aim to address the wider community across all of Pharmacology.